Lilly Presents SURPASS-3 CGM and MRI Sub-studies; Insulet Omnipod 5 Extension Study Results; Onduo Collaborates with Fitbit; EASD 2021 Key Press Releases (Sept 30)

On the fourth day of EASD 2021, four key press releases were observed from Lilly, Insulet, and Onduo. Below FENIX provides insights and context from each respective announcement.

About The Author

Matthew Maryniak

President of Fenix Group International

Matthew has been a thought leader in the high-growth therapeutic areas of diabetes and cardiovascular medicine since 2006, making regular attendance at large and small CV/met scientific meetings and an architect of novel methods for assessing market opportunities. He has over a decade of experience in leading CV/met consulting engagements, is a published author in PM360 and Diabetes Technology & Therapeutics, and has been quoted in The Pink Sheet on anti-thrombotics.

If you receive our email blasts, you already have an account.

Purchase Blast$599.00

You can read the article’s full content online after purchase.